Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company TheraVasc Inc.
DescriptionOral formulation of sodium nitrite
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPeripheral vascular disease (PVD)
Indication DetailsTreat peripheral arterial disease (PAD) in patients with diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today